Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1249520.RAsWS-E1f8Qp0Yoixj8Ts69DefWPWHW99R4d5hTi_3MIQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1249520.RAsWS-E1f8Qp0Yoixj8Ts69DefWPWHW99R4d5hTi_3MIQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1249520.RAsWS-E1f8Qp0Yoixj8Ts69DefWPWHW99R4d5hTi_3MIQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1249520.RAsWS-E1f8Qp0Yoixj8Ts69DefWPWHW99R4d5hTi_3MIQ130_provenance.
- NP1249520.RAsWS-E1f8Qp0Yoixj8Ts69DefWPWHW99R4d5hTi_3MIQ130_assertion description "[Palbociclib (PD-0332991) is an oral, small-molecule inhibitor of cyclin-dependent kinases (CDKs) 4 and 6 with preclinical evidence of growth-inhibitory activity in oestrogen receptor-positive breast cancer cells and synergy with anti-oestrogens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249520.RAsWS-E1f8Qp0Yoixj8Ts69DefWPWHW99R4d5hTi_3MIQ130_provenance.
- NP1249520.RAsWS-E1f8Qp0Yoixj8Ts69DefWPWHW99R4d5hTi_3MIQ130_assertion evidence source_evidence_literature NP1249520.RAsWS-E1f8Qp0Yoixj8Ts69DefWPWHW99R4d5hTi_3MIQ130_provenance.
- NP1249520.RAsWS-E1f8Qp0Yoixj8Ts69DefWPWHW99R4d5hTi_3MIQ130_assertion SIO_000772 25524798 NP1249520.RAsWS-E1f8Qp0Yoixj8Ts69DefWPWHW99R4d5hTi_3MIQ130_provenance.
- NP1249520.RAsWS-E1f8Qp0Yoixj8Ts69DefWPWHW99R4d5hTi_3MIQ130_assertion wasDerivedFrom befree-2016 NP1249520.RAsWS-E1f8Qp0Yoixj8Ts69DefWPWHW99R4d5hTi_3MIQ130_provenance.
- NP1249520.RAsWS-E1f8Qp0Yoixj8Ts69DefWPWHW99R4d5hTi_3MIQ130_assertion wasGeneratedBy ECO_0000203 NP1249520.RAsWS-E1f8Qp0Yoixj8Ts69DefWPWHW99R4d5hTi_3MIQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP1249520.RAsWS-E1f8Qp0Yoixj8Ts69DefWPWHW99R4d5hTi_3MIQ130_provenance.